Therapies for Infantile Haemangiomas: Current Practice and Evolving Perspectives - Summary - MDSpire

Therapies for Infantile Haemangiomas: Current Practice and Evolving Perspectives

  • By

  • B. Nolan

  • C. O’Connor

  • May 9, 2026

Share

Objective:

To review current management strategies for infantile haemangiomas (IH) and highlight emerging insights in treatment, emphasizing the need for individualized care.

Key Findings:
  • Propranolol is the first-line treatment for problematic IH with high efficacy.
  • Alternative beta-blockers may offer benefits in specific cases.
  • Topical treatments are limited to small superficial lesions.
  • Teledermatology enhances access to care.
Interpretation:

The management of infantile haemangiomas has evolved significantly, with propranolol leading as the preferred treatment option due to its effectiveness and safety profile.

Limitations:
  • Not all IH require treatment, and management must be individualized.
  • Potential adverse effects of beta-blockers need consideration.
Conclusion:

Propranolol has revolutionized the treatment of infantile haemangiomas, emphasizing the need for early identification and intervention in high-risk cases.

Original Source(s)

Therapies for Infantile Haemangiomas: Current Practice and Evolving Perspectives

  • by B. Nolan, C. O’Connor

  • May 9, 2026

Related Content

UCI Health is at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Join UCI Health at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, May 29 to June 2 in Chicago, as we showcase how Orange County’s only academic health system is advancing the future of cancer care.

  • by

  • May 8, 2026

  • 5 min
Acupuncture for Nocturia in Survivors of Prostate Cancer

Guest Editor’s Note: Nocturia, waking up from sleep more than once to urinate, is prevalent in survivors of prostate cancer and is associated with a diminished quality of life and a higher mortality t...

Gerald Hsu, MD, PhD, Named Editor-in-Chief of the ASCO Educational Book

ASCO is pleased to announce the appointment of Gerald Hsu, MD, PhD, as the new Editor-in-Chief of the ASCO Educational Book.    

  • by ASCO

  • May 8, 2026

  • 2 min